Towards Unequal Care: Developing Sex Informed Treatments for Psychotic Disorders
30 years of research has highlighted the crucial role of oestrogen in the disease profile of women with psychotic disorders. However, we have not translated this knowledge into tailored treatment strategies. I will present the work conducted during my PhD, which focused on understanding the impact of sex and sex hormones, particularly oestrogen, on the disease trajectory and treatment of psychotic disorders. In the first part, I will explore the interplay between sex, oestrogen, and current treatment strategies for psychosis, emphasising the links between hyperprolactinaemia and clinical outcomes, as well as the influence of sex on the effectiveness and tolerability of antipsychotics. In the second part, I will discuss how we might harness the beneficial effects of oestrogen to optimise treatment strategies, drawing on evidence from clinical trials and birth cohort studies. Lastly, I will provide a brief overview of our current efforts to better understand the impact of sex and sex hormones on the disease course of schizophrenia-spectrum disorders, with the aim of advancing care.
Date: 11 February 2025, 9:30
Venue: Department of Psychiatry, Headington OX3 7JX
Venue Details: Seminar Room
Speaker: Dr Bodyl Brand (University of Oxford)
Organising department: Department of Psychiatry
Organiser: Rania Elgarf (Department of Psychiatry, University of Oxford)
Organiser contact email address: rania.elgarf@psych.ox.ac.uk
Host: Professor Robert McCutcheon (University of Oxford)
Part of: Psychiatry Seminar Series
Booking required?: Not required
Audience: Public
Editor: Rania Elgarf